FDA Approves Apomorphine Infusion Device SPN-830 as New Parkinson Treatment
In TOLEDO, the intervention group, with a mean final drug dose of 4.68 mg/hour, showed significant improvements, including a reduction in OFF time of ...Powered by WPeMatico